Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Sulfaphenazole | hsa00020 | Citrate cycle (TCA cycle) | 6.05E-03 | 3 | Q9P2R7, P40925, O14521 | SUCLA2, MDH1, SDHD | More | | Sulfaphenazole | hsa00052 | Galactose metabolism | 4.27E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Sulfaphenazole | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Sulfaphenazole | hsa00190 | Oxidative phosphorylation | 3.20E-02 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Sulfaphenazole | hsa00220 | Arginine biosynthesis | 4.40E-02 | 1 | P15104 | GLUL | More | | Sulfaphenazole | hsa00310 | Lysine degradation | 4.57E-02 | 2 | Q96KQ7, Q02809 | EHMT2, PLOD1 | More | | Sulfaphenazole | hsa00500 | Starch and sucrose metabolism | 1.91E-04 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Sulfaphenazole | hsa00531 | Glycosaminoglycan degradation | 1.05E-03 | 2 | P15586, P34059 | GNS, GALNS | More | | Sulfaphenazole | hsa00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 3.30E-02 | 1 | Q9Y2C2 | UST | More | | Sulfaphenazole | hsa00562 | Inositol phosphate metabolism | 2.00E-02 | 4 | P27987, P19174, P42338, Q02252 | ITPKB, PLCG1, PIK3CB, ALDH6A1 | More | | Sulfaphenazole | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Sulfaphenazole | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Sulfaphenazole | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Sulfaphenazole | hsa00630 | Glyoxylate and dicarboxylate metabolism | 1.03E-04 | 2 | P40925, P15104 | MDH1, GLUL | More | | Sulfaphenazole | hsa00640 | Propanoate metabolism | 3.83E-02 | 2 | Q02252, Q9P2R7 | ALDH6A1, SUCLA2 | More | | Sulfaphenazole | hsa00730 | Thiamine metabolism | 1.55E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Sulfaphenazole | hsa00740 | Riboflavin metabolism | 4.77E-02 | 1 | P30043 | BLVRB | More | | Sulfaphenazole | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Sulfaphenazole | hsa00920 | Sulfur metabolism | 3.18E-02 | 1 | Q16762 | TST | More | | Sulfaphenazole | hsa00970 | Aminoacyl-tRNA biosynthesis | 7.84E-04 | 4 | O95363, P54136, P14868, Q15046 | FARS2, RARS1, DARS, KARS | More | | Sulfaphenazole | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Sulfaphenazole | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Sulfaphenazole | hsa01100 | Metabolic pathways | 4.43E-02 | 23 | Q9NR34, P05089, P32320, P22748, P55809, P06280, Q16875, O43286, O43451, P05186, P24666, Q9HCC0, P33121, P57054, Q9UNP4, Q9BX95, P32321, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737 | MAN1C1, ARG1, CDA, CA4, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, ALPL, ACP1, MCCC2, ACSL1, PIGP, ST3GAL5, SGPP1, DCTD, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL | More | | Sulfaphenazole | hsa01200 | Carbon metabolism | 8.75E-03 | 5 | P04406, P40925, O14521, Q9P2R7, Q02252 | GAPDH, MDH1, SDHD, SUCLA2, ALDH6A1 | More | | Sulfaphenazole | hsa01523 | Antifolate resistance | 1.68E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | | Sulfaphenazole | hsa01524 | Platinum drug resistance | 4.78E-02 | 1 | P31751 | AKT2 | More | | Sulfaphenazole | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | | Sulfaphenazole | hsa03010 | Ribosome | 7.34E-03 | 6 | P62753, P62829, P62888, P61927, P61513, P36578 | RPS6, RPL23, RPL30, RPL37, RPL37A, RPL4 | More | | Sulfaphenazole | hsa03013 | RNA transport | 2.40E-03 | 12 | P52298, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, P78345, Q14240, Q9BZI7, Q9Y6A5, Q06787 | NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, RPP38, EIF4A2, UPF3B, TACC3, FMR1 | More | | Sulfaphenazole | hsa03015 | mRNA surveillance pathway | 6.77E-03 | 6 | Q9BZI7, O60942, O43148, O94913, P52298, Q53GS7 | UPF3B, RNGTT, RNMT, PCF11, NCBP2, GLE1 | More | | Sulfaphenazole | hsa03020 | RNA polymerase | 2.06E-03 | 3 | P30876, P24928, P62487 | POLR2B, POLR2A, POLR2G | More | | Sulfaphenazole | hsa03022 | Basal transcription factors | 2.41E-02 | 1 | Q12962 | TAF10 | More | | Sulfaphenazole | hsa03040 | Spliceosome | 1.81E-06 | 17 | Q14562, O43143, O60508, O14776, P08579, O75940, P52298, P09651, O75494, Q07955, Q01130, Q13243, P11142, O95777, O43447, O43395, P61326 | DHX8, DHX15, CDC40, TCERG1, SNRPB2, SMNDC1, NCBP2, HNRNPA1, FUSIP1, SFRS1, SFRS2, SFRS5, HSPA8, LSM8, PPIH, PRPF3, MAGOH | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.888 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | -0.708 | P27707 | DCK | Deoxycytidine kinase | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | -0.726 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.953 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.76 | P27707 | DCK | Deoxycytidine kinase | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.816 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.838 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.837 | P27707 | DCK | Deoxycytidine kinase | O14776 | TCERG1 | Transcription elongation regulator 1 | 0.757 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.788 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.702 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | O75940 | SMNDC1 | Survival of motor neuron-related-splicing factor 30 | -0.812 | P27707 | DCK | Deoxycytidine kinase | O75940 | SMNDC1 | Survival of motor neuron-related-splicing factor 30 | 0.84 | P27707 | DCK | Deoxycytidine kinase | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | 0.769 | P27707 | DCK | Deoxycytidine kinase | P09651 | HNRNPA1 | Heterogeneous nuclear ribonucleoprotein A1 | 0.736 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | O75494 | FUSIP1 | Serine/arginine-rich splicing factor 10 | -0.809 | P27707 | DCK | Deoxycytidine kinase | O75494 | FUSIP1 | Serine/arginine-rich splicing factor 10 | 0.824 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.935 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.839 | P27707 | DCK | Deoxycytidine kinase | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.804 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.882 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.835 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.886 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.775 | P27707 | DCK | Deoxycytidine kinase | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.757 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.746 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | O95777 | LSM8 | U6 snRNA-associated Sm-like protein LSm8 | -0.891 | P27707 | DCK | Deoxycytidine kinase | O95777 | LSM8 | U6 snRNA-associated Sm-like protein LSm8 | 0.797 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.761 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | O43395 | PRPF3 | U4/U6 small nuclear ribonucleoprotein Prp3 | -0.747 | P27707 | DCK | Deoxycytidine kinase | P61326 | MAGOH | Protein mago nashi homolog | 0.732 |
| Sulfaphenazole | hsa03060 | Protein export | 4.97E-03 | 3 | Q15070, P37108, Q15005 | OXA1L, SRP14, SPCS2 | More | | Sulfaphenazole | hsa03320 | PPAR signaling pathway | 3.60E-02 | 1 | Q13418 | ILK | More | | Sulfaphenazole | hsa03450 | Non-homologous end-joining | 4.21E-02 | 1 | P13010 | XRCC5 | More | | Sulfaphenazole | hsa04012 | ErbB signaling pathway | 2.00E-02 | 4 | P16333, P17252, P19174, P42338 | NCK1, PRKCA, PLCG1, PIK3CB | More | | Sulfaphenazole | hsa04014 | Ras signaling pathway | 1.48E-04 | 11 | P31751, P42338, P20827, P49767, Q13009, P17252, P14921, P0DP23, P62873, P50151, P19174 | AKT2, PIK3CB, EFNA1, VEGFC, TIAM1, PRKCA, ETS1, CALM1, GNB1, GNG10, PLCG1 | More | | Sulfaphenazole | hsa04015 | Rap1 signaling pathway | 1.93E-04 | 12 | P20827, P49767, P11215, P25116, Q8TEU7, Q13009, P42338, P31751, P0DP23, P08514, P17252, P19174 | EFNA1, VEGFC, ITGAM, F2R, RAPGEF6, TIAM1, PIK3CB, AKT2, CALM1, ITGA2B, PRKCA, PLCG1 | More | | Sulfaphenazole | hsa04020 | Calcium signaling pathway | 4.34E-02 | 6 | P27987, P17252, O15399, P19174, P0DP23, P49767 | ITPKB, PRKCA, GRIN2D, PLCG1, CALM1, VEGFC | More | | Sulfaphenazole | hsa04022 | cGMP-PKG signaling pathway | 5.07E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Sulfaphenazole | hsa04024 | cAMP signaling pathway | 4.12E-03 | 7 | P42338, P31751, P0DP23, Q13370, O15399, P25963, Q13009 | PIK3CB, AKT2, CALM1, PDE3B, GRIN2D, NFKBIA, TIAM1 | More | | Sulfaphenazole | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 1.28E-02 | 8 | P09341, P25024, P25025, P47992, Q9UBD3, Q13651, P09603, P01375 | CXCL1, CXCR1, CXCR2, XCL1, XCL2, IL10RA, CSF1, TNF | More | | Sulfaphenazole | hsa04062 | Chemokine signaling pathway | 1.07E-03 | 19 | P25024, P25025, P09341, P47992, Q9UBD3, P07948, P42338, P19174, P62873, P63218, P50151, P43250, Q08881, Q13009, P14598, P22694, P42224, P25963, P49841 | CXCR1, CXCR2, CXCL1, XCL1, XCL2, LYN, PIK3CB, PLCG1, GNB1, GNG5, GNG10, GRK6, ITK, TIAM1, NCF1, PRKACB, STAT1, NFKBIA, GSK3B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | 0.901 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.917 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.859 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P47992 | XCL1 | Lymphotactin | -0.797 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q9UBD3 | XCL2 | Cytokine SCM-1 beta | -0.797 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.713 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.743 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.785 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.837 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.743 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.712 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.737 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P43250 | GRK6 | G protein-coupled receptor kinase 6 | -0.701 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.847 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | -0.792 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.908 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | -0.758 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.841 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.73 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.794 |
| Sulfaphenazole | hsa04064 | NF-kappa B signaling pathway | 7.60E-06 | 18 | P10415, O00463, P14778, P01584, P01375, Q04759, Q9UDY8, Q13077, Q16548, P07948, P06239, Q8WV28, Q13315, P63279, P24522, Q8NHW4, P09341, Q9NQC7 | BCL2, TRAF5, IL1R1, IL1B, TNF, PRKCQ, MALT1, TRAF1, BCL2A1, LYN, LCK, BLNK, ATM, UBE2I, GADD45A, CCL4L2, CXCL1, CYLD | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.713 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.896 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.717 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.823 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P01584 | IL1B | Interleukin-1 beta | 0.799 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P01375 | TNF | Tumor necrosis factor | 0.782 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.807 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.73 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.889 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.875 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.701 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.713 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.809 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q8WV28 | BLNK | B-cell linker protein | -0.816 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q13315 | ATM | Serine-protein kinase ATM | 0.723 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.756 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.805 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.796 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.734 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.859 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.7 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.789 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.825 |
| Sulfaphenazole | hsa04070 | Phosphatidylinositol signaling system | 3.29E-03 | 6 | P19174, P0DP23, P42338, P23743, P27987, P17252 | PLCG1, CALM1, PIK3CB, DGKA, ITPKB, PRKCA | More | | Sulfaphenazole | hsa04071 | Sphingolipid signaling pathway | 6.65E-04 | 7 | P21453, Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415 | S1PR1, EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2 | More | | Sulfaphenazole | hsa04080 | Neuroactive ligand-receptor interaction | 1.00E-02 | 7 | P08311, Q15722, P21453, Q9H228, O00398, P21730, P07550 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, C5AR1, ADRB2 | More | | Sulfaphenazole | hsa04110 | Cell cycle | 6.63E-04 | 6 | P06493, O60566, P30304, P33981, P42773, P01106 | CDK1, BUB1B, CDC25A, TTK, CDKN2C, MYC | More | | Sulfaphenazole | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | | Sulfaphenazole | hsa04122 | Sulfur relay system | 3.18E-02 | 1 | Q16762 | TST | More | | Sulfaphenazole | hsa04140 | Autophagy - animal | 1.44E-03 | 7 | Q9Y4H2, Q9NQL2, P22694, Q14643, P10415, Q9H1Y0, Q04759 | IRS2, RRAGD, PRKACB, ITPR1, BCL2, ATG5, PRKCQ | More | | Sulfaphenazole | hsa04142 | Lysosome | 8.21E-05 | 11 | P43234, P06865, P15586, P22304, P34059, P38571, Q13510, P07602, Q9NRA2, P49281, P61916 | CTSO, HEXA, GNS, IDS, GALNS, LIPA, ASAH1, PSAP, SLC17A5, SLC11A2, NPC2 | More | | Sulfaphenazole | hsa04144 | Endocytosis | 1.67E-02 | 8 | P0DMV8, Q9H444, O75351, P62491, Q96B97, Q15438, Q14161, Q9UMY4 | HSPA1A, CHMP4B, VPS4B, RAB11A, SH3KBP1, PSCD1, GIT2, SNX12 | More | | Sulfaphenazole | hsa04145 | Phagosome | 3.23E-03 | 9 | P63261, Q15080, P14598, Q13509, P68371, P05164, O60603, P35443, P13765 | ACTG1, NCF4, NCF1, TUBB3, TUBB2C, MPO, TLR2, THBS4, HLA-DOB | More | | Sulfaphenazole | hsa04146 | Peroxisome | 2.42E-02 | 5 | O43933, P56589, Q9UKG9, O75521, P33121 | PEX1, PEX3, CROT, ECI2, ACSL1 | More | | Sulfaphenazole | hsa04151 | PI3K-Akt signaling pathway | 1.43E-02 | 12 | P42338, P20827, P49767, P08238, P62873, P50151, P16144, O15335, Q13751, P14784, P01568, P17252 | PIK3CB, EFNA1, VEGFC, HSP90AB1, GNB1, GNG10, ITGB4, CHAD, LAMB3, IL2RB, IFNA21, PRKCA | More | | Sulfaphenazole | hsa04210 | Apoptosis | 2.35E-03 | 9 | Q13315, P04637, P10415, O76075, P24522, Q16548, P43234, Q14643, P63261 | ATM, TP53, BCL2, DFFB, GADD45A, BCL2A1, CTSO, ITPR1, ACTG1 | More | | Sulfaphenazole | hsa04213 | Longevity regulating pathway - multiple species | 2.82E-02 | 3 | Q08828, P51828, P0DMV8 | ADCY1, ADCY7, HSPA1A | More | | Sulfaphenazole | hsa04216 | Ferroptosis | 1.45E-02 | 2 | P04637, P49281 | TP53, SLC11A2 | More | | Sulfaphenazole | hsa04217 | Necroptosis | 8.72E-07 | 18 | P01375, P01568, P48023, Q13489, Q9NQC7, Q13546, P42224, Q14765, P07900, P08238, P15104, P01584, P07384, Q6FI13, Q99878, P10415, Q9H444, O43633 | TNF, IFNA21, FASLG, BIRC3, CYLD, RIPK1, STAT1, STAT4, HSP90AA1, HSP90AB1, GLUL, IL1B, CAPN1, H2AC18; H2AC19, H2AC14, BCL2, CHMP4B, CHMP2A | More | | Sulfaphenazole | hsa04218 | Cellular senescence | 3.65E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Sulfaphenazole | hsa04261 | Adrenergic signaling in cardiomyocytes | 4.57E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Sulfaphenazole | hsa04270 | Vascular smooth muscle contraction | 9.46E-04 | 6 | P0DP23, Q08828, P51828, P35579, P35749, P35318 | CALM1, ADCY1, ADCY7, MYH9, MYH11, ADM | More | | Sulfaphenazole | hsa04340 | Hedgehog signaling pathway | 3.09E-02 | 3 | P22694, Q13635, P10415 | PRKACB, PTCH1, BCL2 | More | | Sulfaphenazole | hsa04360 | Axon guidance | 2.13E-03 | 7 | P16333, P20827, O95631, P17252, P42338, P23528, P19174 | NCK1, EFNA1, NTN1, PRKCA, PIK3CB, CFL1, PLCG1 | More | | Sulfaphenazole | hsa04370 | VEGF signaling pathway | 4.06E-03 | 4 | P19174, P31751, P42338, P17252 | PLCG1, AKT2, PIK3CB, PRKCA | More | | Sulfaphenazole | hsa04371 | Apelin signaling pathway | 3.23E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Sulfaphenazole | hsa04380 | Osteoclast differentiation | 2.72E-04 | 8 | Q9NQC7, Q9UQC2, Q16539, P31751, P14778, O75015, P01375, Q8N149 | CYLD, GAB2, MAPK14, AKT2, IL1R1, FCGR3B, TNF, LILRA2 | More | | Sulfaphenazole | hsa04510 | Focal adhesion | 1.14E-03 | 11 | P16144, O75369, P42338, Q15942, P17252, O15335, Q13751, Q13489, P10415, P49767, P63261 | ITGB4, FLNB, PIK3CB, ZYX, PRKCA, CHAD, LAMB3, BIRC3, BCL2, VEGFC, ACTG1 | More | | Sulfaphenazole | hsa04512 | ECM-receptor interaction | 3.73E-02 | 2 | P07359, P08514 | GP1BA, ITGA2B | More | | Sulfaphenazole | hsa04514 | Cell adhesion molecules | 8.19E-03 | 3 | P16109, P56750, O00501 | SELP, CLDN17, CLDN5 | More | | Sulfaphenazole | hsa04530 | Tight junction | 2.47E-05 | 5 | Q8TEU7, P16989, P56750, O00501, Q14247 | RAPGEF6, CSDA, CLDN17, CLDN5, CTTN | More | | Sulfaphenazole | hsa04610 | Complement and coagulation cascades | 1.03E-03 | 3 | P25116, P09871, P0C0L4 | F2R, C1S, C4A | More | | Sulfaphenazole | hsa04611 | Platelet activation | 5.18E-05 | 5 | P25116, P08514, Q15746, Q8WYR1, P07359 | F2R, ITGA2B, MYLK, PIK3R5, GP1BA | More | | Sulfaphenazole | hsa04612 | Antigen processing and presentation | 5.83E-03 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Sulfaphenazole | hsa04613 | Neutrophil extracellular trap formation | 1.76E-05 | 20 | P16109, O60603, P05164, P08246, Q9UM07, Q6FI13, Q93077, P62807, O60814, P68431, Q15080, P20160, P08311, O75015, P21730, P08514, P21462, P07359, O43315, Q16539 | SELP, TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, AZU1, CTSG, FCGR3B, C5AR1, ITGA2B, FPR1, GP1BA, AQP9, MAPK14 | More | | Sulfaphenazole | hsa04620 | Toll-like receptor signaling pathway | 4.78E-02 | 1 | P31751 | AKT2 | More | | Sulfaphenazole | hsa04621 | NOD-like receptor signaling pathway | 7.10E-05 | 17 | P01584, P07900, Q16539, Q14643, P21796, P10599, Q9H1Y0, P43490, O00463, P29728, Q05823, P01375, P09341, P49913, P59665, P59666, P12838 | IL1B, HSP90AA1, MAPK14, ITPR1, VDAC1, TXN, ATG5, PBEF1, TRAF5, OAS2, RNASEL, TNF, CXCL1, CAMP, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Sulfaphenazole | hsa04622 | RIG-I-like receptor signaling pathway | 1.81E-02 | 1 | Q9NQC7 | CYLD | More | | Sulfaphenazole | hsa04623 | Cytosolic DNA-sensing pathway | 5.86E-05 | 5 | P01584, P01568, Q13546, P25963, Q8NHW4 | IL1B, IFNA21, RIPK1, NFKBIA, CCL4L2 | More | | Sulfaphenazole | hsa04625 | C-type lectin receptor signaling pathway | 2.27E-04 | 7 | Q9ULY5, Q9NQC7, P20749, P01375, P31751, P0DP23, Q16539 | CLEC4E, CYLD, BCL3, TNF, AKT2, CALM1, MAPK14 | More | | Sulfaphenazole | hsa04640 | Hematopoietic cell lineage | 1.62E-04 | 15 | P13612, P14778, P27930, P15144, P11836, P25063, P07766, P09693, P01732, P01730, P06127, P09564, P13765, P01375, P09603 | ITGA4, IL1R1, IL1R2, ANPEP, MS4A1, CD24, CD3E, CD3G, CD8A, CD4, CD5, CD7, HLA-DOB, TNF, CSF1 | More | | Sulfaphenazole | hsa04650 | Natural killer cell mediated cytotoxicity | 2.72E-05 | 10 | P01375, P78314, P06239, O60880, P20963, Q13241, P26718, O75015, P26717, P26715 | TNF, SH3BP2, LCK, SH2D1A, CD247, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | | Sulfaphenazole | hsa04657 | IL-17 signaling pathway | 2.89E-06 | 15 | P25963, P07900, P08238, O00463, Q07955, Q16539, P49841, P09341, P14780, Q9UJX4, P04141, P80188, P01375, P06702, P01584 | NFKBIA, HSP90AA1, HSP90AB1, TRAF5, SFRS1, MAPK14, GSK3B, CXCL1, MMP9, ANAPC5, CSF2, LCN2, TNF, S100A9, IL1B | More | | Sulfaphenazole | hsa04658 | Th1 and Th2 cell differentiation | 2.14E-07 | 11 | Q04759, P07766, P20963, P09693, Q16539, P06239, Q14765, P23771, Q9UL17, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, LCK, STAT4, GATA3, TBX21, HLA-DOB, RUNX3 | More | | Sulfaphenazole | hsa04659 | Th17 cell differentiation | 2.91E-05 | 16 | P25963, Q04759, Q16539, P19174, P06239, P42224, P14784, P13765, P14778, P40189, Q9UL17, P23771, P08238, P07766, P09693, P20963 | NFKBIA, PRKCQ, MAPK14, PLCG1, LCK, STAT1, IL2RB, HLA-DOB, IL1R1, IL6ST, TBX21, GATA3, HSP90AB1, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.73 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q04759 | PRKCQ | Protein kinase C theta type | -0.807 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.849 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.785 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.809 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.841 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.865 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.748 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.823 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P40189 | IL6ST | Interleukin-6 receptor subunit beta | 0.748 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.927 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.765 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.802 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.782 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.815 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.862 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 |
| Sulfaphenazole | hsa04660 | T cell receptor signaling pathway | 2.44E-05 | 14 | P01375, Q9UDY8, Q04759, P10747, O95267, Q08881, P07766, P20963, P09693, P01732, Q13191, P06239, Q16539, P49841 | TNF, MALT1, PRKCQ, CD28, RASGRP1, ITK, CD3E, CD247, CD3G, CD8A, CBLB, LCK, MAPK14, GSK3B | More | | Sulfaphenazole | hsa04662 | B cell receptor signaling pathway | 1.60E-04 | 6 | P31751, P42338, P60033, P07948, P21854, Q8N149 | AKT2, PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Sulfaphenazole | hsa04664 | Fc epsilon RI signaling pathway | 2.15E-06 | 10 | P01375, P31751, Q16539, P42338, P17252, Q9UQC2, P07948, P19174, P09917, P20292 | TNF, AKT2, MAPK14, PIK3CB, PRKCA, GAB2, LYN, PLCG1, ALOX5, ALOX5AP | More | | Sulfaphenazole | hsa04666 | Fc gamma R-mediated phagocytosis | 8.08E-03 | 5 | P42338, P19174, P23528, P14598, P17252 | PIK3CB, PLCG1, CFL1, NCF1, PRKCA | More | | Sulfaphenazole | hsa04668 | TNF signaling pathway | 2.21E-02 | 5 | P01375, O00463, Q16539, P20749, P14780 | TNF, TRAF5, MAPK14, BCL3, MMP9 | More | | Sulfaphenazole | hsa04710 | Circadian rhythm | 4.40E-02 | 1 | O15516 | CLOCK | More | | Sulfaphenazole | hsa04713 | Circadian entrainment | 1.24E-02 | 5 | O15399, P0DP23, P17252, P62873, P50151 | GRIN2D, CALM1, PRKCA, GNB1, GNG10 | More | | Sulfaphenazole | hsa04722 | Neurotrophin signaling pathway | 1.26E-03 | 5 | P31751, P49841, O43524, P48023, P0DP23 | AKT2, GSK3B, FOXO3, FASLG, CALM1 | More | | Sulfaphenazole | hsa04723 | Retrograde endocannabinoid signaling | 4.40E-02 | 5 | Q14643, P63218, P50151, P22694, Q16539 | ITPR1, GNG5, GNG10, PRKACB, MAPK14 | More | | Sulfaphenazole | hsa04724 | Glutamatergic synapse | 1.44E-04 | 6 | O15399, P17252, P62873, P63218, P50151, P15104 | GRIN2D, PRKCA, GNB1, GNG5, GNG10, GLUL | More | | Sulfaphenazole | hsa04725 | Cholinergic synapse | 4.49E-03 | 5 | P17252, P62873, P63218, P50151, P42338 | PRKCA, GNB1, GNG5, GNG10, PIK3CB | More | | Sulfaphenazole | hsa04726 | Serotonergic synapse | 2.54E-02 | 5 | P17252, P62873, P50151, P33260, P09917 | PRKCA, GNB1, GNG10, CYP2C18, ALOX5 | More | | Sulfaphenazole | hsa04727 | GABAergic synapse | 5.11E-04 | 5 | P62873, P63218, P50151, P15104, P17252 | GNB1, GNG5, GNG10, GLUL, PRKCA | More | | Sulfaphenazole | hsa04728 | Dopaminergic synapse | 3.23E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Sulfaphenazole | hsa04740 | Olfactory transduction | 9.46E-04 | 2 | Q9H255, P0DP23 | OR51E2, CALM1 | More | | Sulfaphenazole | hsa04742 | Taste transduction | 1.01E-02 | 1 | P30939 | HTR1F | More | | Sulfaphenazole | hsa04744 | Phototransduction | 2.09E-04 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Sulfaphenazole | hsa04750 | Inflammatory mediator regulation of TRP channels | 1.83E-03 | 10 | P14778, P01584, Q08828, P51828, P22694, Q16539, Q14643, P24723, Q04759, P0DP23 | IL1R1, IL1B, ADCY1, ADCY7, PRKACB, MAPK14, ITPR1, PRKCH, PRKCQ, CALM1 | More | | Sulfaphenazole | hsa04810 | Regulation of actin cytoskeleton | 2.58E-02 | 3 | Q15746, P08514, P25116 | MYLK, ITGA2B, F2R | More | | Sulfaphenazole | hsa04910 | Insulin signaling pathway | 9.82E-04 | 2 | P0DP23, P31751 | CALM1, AKT2 | More | | Sulfaphenazole | hsa04914 | Progesterone-mediated oocyte maturation | 1.24E-02 | 5 | P42338, Q13370, Q9UJX4, P30304, P08238 | PIK3CB, PDE3B, ANAPC5, CDC25A, HSP90AB1 | More | | Sulfaphenazole | hsa04915 | Estrogen signaling pathway | 3.76E-03 | 6 | Q08828, P51828, P31751, P0DMV8, P0DP23, Q15788 | ADCY1, ADCY7, AKT2, HSPA1A, CALM1, NCOA1 | More | | Sulfaphenazole | hsa04916 | Melanogenesis | 4.78E-02 | 1 | P0DP23 | CALM1 | More | | Sulfaphenazole | hsa04917 | Prolactin signaling pathway | 2.41E-02 | 1 | P31751 | AKT2 | More | | Sulfaphenazole | hsa04920 | Adipocytokine signaling pathway | 4.19E-02 | 1 | P31751 | AKT2 | More | | Sulfaphenazole | hsa04922 | Glucagon signaling pathway | 3.14E-03 | 6 | P22694, P06737, Q12778, P31751, P0DP23, Q14643 | PRKACB, PYGL, FOXO1, AKT2, CALM1, ITPR1 | More | | Sulfaphenazole | hsa04923 | Regulation of lipolysis in adipocytes | 3.01E-02 | 1 | P31751 | AKT2 | More | | Sulfaphenazole | hsa04924 | Renin secretion | 2.12E-03 | 4 | P22694, P07550, Q14643, P0DP23 | PRKACB, ADRB2, ITPR1, CALM1 | More | | Sulfaphenazole | hsa04926 | Relaxin signaling pathway | 3.06E-04 | 8 | P25963, P42338, P62873, P63218, P50151, P49767, P17252, P49407 | NFKBIA, PIK3CB, GNB1, GNG5, GNG10, VEGFC, PRKCA, ARRB1 | More | | Sulfaphenazole | hsa04928 | Parathyroid hormone synthesis, secretion and action | 4.23E-02 | 4 | Q14643, P22694, P23771, P10415 | ITPR1, PRKACB, GATA3, BCL2 | More | | Sulfaphenazole | hsa04929 | GnRH secretion | 3.61E-03 | 3 | P42338, P31751, P49407 | PIK3CB, AKT2, ARRB1 | More | | Sulfaphenazole | hsa04932 | Non-alcoholic fatty liver disease | 9.52E-05 | 10 | P01375, P49841, O43521, P48023, O75460, P01584, P13073, P12074, O15239, O95298 | TNF, GSK3B, BCL2L11, FASLG, ERN1, IL1B, COX4I1, COX6A1, NDUFA1, NDUFC2 | More | | Sulfaphenazole | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.43E-02 | 5 | P42224, P42338, P49767, P17252, P19174 | STAT1, PIK3CB, VEGFC, PRKCA, PLCG1 | More | | Sulfaphenazole | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Sulfaphenazole | hsa04960 | Aldosterone-regulated sodium reabsorption | 4.40E-02 | 1 | O00141 | SGK | More | | Sulfaphenazole | hsa04962 | Vasopressin-regulated water reabsorption | 7.22E-03 | 2 | P52566, P62491 | ARHGDIB, RAB11A | More | | Sulfaphenazole | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Sulfaphenazole | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Sulfaphenazole | hsa04970 | Salivary secretion | 1.11E-02 | 3 | Q08828, P51828, P0DP23 | ADCY1, ADCY7, CALM1 | More | | Sulfaphenazole | hsa04971 | Gastric acid secretion | 4.78E-02 | 1 | P0DP23 | CALM1 | More | | Sulfaphenazole | hsa04973 | Carbohydrate digestion and absorption | 2.41E-02 | 1 | P31751 | AKT2 | More | | Sulfaphenazole | hsa04976 | Bile secretion | 4.78E-02 | 3 | Q08828, P51828, Q14032 | ADCY1, ADCY7, BAAT | More | | Sulfaphenazole | hsa05010 | Alzheimer disease | 8.59E-04 | 3 | Q00535, P0DP23, P31751 | CDK5, CALM1, AKT2 | More | | Sulfaphenazole | hsa05016 | Huntington disease | 2.46E-02 | 9 | O95298, P13073, P12074, P24928, P30876, P62487, O75460, P28070, O00232 | NDUFC2, COX4I1, COX6A1, POLR2A, POLR2B, POLR2G, ERN1, PSMB4, PSMD12 | More | | Sulfaphenazole | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.81E-02 | 9 | O15399, Q13509, P68371, P10415, Q13561, P07384, Q00535, P04628, P0DP23 | GRIN2D, TUBB3, TUBB2C, BCL2, DCTN2, CAPN1, CDK5, WNT1, CALM1 | More | | Sulfaphenazole | hsa05030 | Cocaine addiction | 4.19E-02 | 1 | Q00535 | CDK5 | More | | Sulfaphenazole | hsa05031 | Amphetamine addiction | 4.78E-02 | 1 | P0DP23 | CALM1 | More | | Sulfaphenazole | hsa05032 | Morphine addiction | 1.24E-02 | 5 | P62873, P50151, Q13370, P17252, P43250 | GNB1, GNG10, PDE3B, PRKCA, GRK6 | More | | Sulfaphenazole | hsa05034 | Alcoholism | 1.96E-04 | 6 | Q96RR4, Q93077, P62807, O60814, P84243, P68431 | CAMKK2, HIST1H2AC, HIST1H2BC, H2BC12, H3F3A, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Sulfaphenazole | hsa05110 | Vibrio cholerae infection | 3.15E-02 | 3 | Q13488, P17252, P19174 | TCIRG1, PRKCA, PLCG1 | More | | Sulfaphenazole | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.82E-03 | 5 | Q16539, P09341, P25024, P25025, P07948 | MAPK14, CXCL1, CXCR1, CXCR2, LYN | More | | Sulfaphenazole | hsa05130 | Pathogenic Escherichia coli infection | 7.39E-03 | 4 | Q14247, P56750, O00501, P25116 | CTTN, CLDN17, CLDN5, F2R | More | | Sulfaphenazole | hsa05131 | Shigellosis | 3.15E-02 | 12 | P01375, O00463, P14778, Q16539, Q04759, P61088, Q9NQL2, Q9H1Y0, P12814, Q14643, P49841, P21796 | TNF, TRAF5, IL1R1, MAPK14, PRKCQ, UBE2N, RRAGD, ATG5, ACTN1, ITPR1, GSK3B, VDAC1 | More | | Sulfaphenazole | hsa05132 | Salmonella infection | 6.08E-05 | 15 | P25963, P08238, P63261, Q13546, Q13489, P10415, P04406, O75369, Q96A32, O60603, Q9BQS8, Q13561, Q13509, P68371, P49754 | NFKBIA, HSP90AB1, ACTG1, RIPK1, BIRC3, BCL2, GAPDH, FLNB, MYLPF, TLR2, FYCO1, DCTN2, TUBB3, TUBB2C, VPS41 | More | | Sulfaphenazole | hsa05133 | Pertussis | 1.86E-03 | 3 | P09871, P0C0L4, Q02556 | C1S, C4A, IRF8 | More | | Sulfaphenazole | hsa05134 | Legionellosis | 2.82E-02 | 3 | P01584, Q9NR31, P0DMV8 | IL1B, SAR1A, HSPA1A | More | | Sulfaphenazole | hsa05140 | Leishmaniasis | 1.65E-03 | 10 | O75015, P14598, P42224, P13765, O60603, P25963, P29350, P49006, Q16539, Q15080 | FCGR3B, NCF1, STAT1, HLA-DOB, TLR2, NFKBIA, PTPN6, MARCKSL1, MAPK14, NCF4 | More | | Sulfaphenazole | hsa05143 | African trypanosomiasis | 7.50E-04 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | | Sulfaphenazole | hsa05144 | Malaria | 3.76E-03 | 6 | P60033, P69905, P68871, P01375, P35443, P26718 | CD81, HBA2, HBB, TNF, THBS4, KLRK1 | More | | Sulfaphenazole | hsa05145 | Toxoplasmosis | 3.45E-02 | 6 | P25963, Q13489, P42224, P09917, Q13751, P11142 | NFKBIA, BIRC3, STAT1, ALOX5, LAMB3, HSPA8 | More | | Sulfaphenazole | hsa05146 | Amoebiasis | 1.16E-03 | 9 | P09341, P14778, P27930, P01375, O60603, P05089, P22694, P12814, P08311 | CXCL1, IL1R1, IL1R2, TNF, TLR2, ARG1, PRKACB, ACTN1, CTSG | More | | Sulfaphenazole | hsa05150 | Staphylococcus aureus infection | 6.29E-05 | 8 | P21730, P21462, O75015, Q14532, P59665, P59666, P12838, P49913 | C5AR1, FPR1, FCGR3B, KRT32, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | | Sulfaphenazole | hsa05152 | Tuberculosis | 3.80E-03 | 10 | Q13488, Q15075, P0DP23, P42224, P25208, O60603, P31751, P10415, P01568, Q9UDY8 | TCIRG1, EEA1, CALM1, STAT1, NFYB, TLR2, AKT2, BCL2, IFNA21, MALT1 | More | | Sulfaphenazole | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Sulfaphenazole | hsa05162 | Measles | 3.18E-02 | 4 | P23458, P0DMV8, P01584, Q9NP90 | JAK1, HSPA1A, IL1B, RAB9B | More | | Sulfaphenazole | hsa05163 | Human cytomegalovirus infection | 5.74E-07 | 25 | P31751, P42338, P01375, P25963, P62873, P63218, P50151, Q14643, P0DP23, Q8NHW4, Q08828, P51828, P22694, P23458, P49841, P14778, P01584, P17252, Q13651, P25025, Q16539, P04637, O00463, P30101, P01568 | AKT2, PIK3CB, TNF, NFKBIA, GNB1, GNG5, GNG10, ITPR1, CALM1, CCL4L2, ADCY1, ADCY7, PRKACB, JAK1, GSK3B, IL1R1, IL1B, PRKCA, IL10RA, CXCR2, MAPK14, TP53, TRAF5, PDIA3, IFNA21 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 1 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.743 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P01375 | TNF | Tumor necrosis factor | 0.782 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P01375 | TNF | Tumor necrosis factor | 0.732 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.73 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.837 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.743 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.712 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.737 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.763 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.728 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P0DP23 | CALM1 | Calmodulin-1 | 0.926 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P0DP23 | CALM1 | Calmodulin-1 | 0.822 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.84 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.834 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | -0.758 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 1 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.794 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.78 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 1 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.823 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.778 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P01584 | IL1B | Interleukin-1 beta | 0.799 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P17252 | PRKCA | Protein kinase C alpha type | -0.725 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | -0.702 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | 0.799 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.917 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.889 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.861 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.849 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.78 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P04637 | TP53 | Cellular tumor antigen p53 | -0.823 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.896 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.734 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P30101 | PDIA3 | Protein disulfide-isomerase A3 | 0.739 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.868 |
| Sulfaphenazole | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 3.63E-04 | 10 | P01568, P31751, P42224, P25963, P42338, P40189, P62873, P50151, P19174, P0DP23 | IFNA21, AKT2, STAT1, NFKBIA, PIK3CB, IL6ST, GNB1, GNG10, PLCG1, CALM1 | More | | Sulfaphenazole | hsa05168 | Herpes simplex virus 1 infection | 2.03E-07 | 25 | Q9UKJ0, Q06124, O60603, P25963, P01568, Q05823, P42224, Q07955, Q01130, Q13243, Q13489, P30101, P42338, Q9Y2A4, Q13398, P51522, Q9NR11, Q9HCX3, P17097, P17038, Q03923, P52738, O75820, Q9UDV6, P10415 | PILRB, PTPN11, TLR2, NFKBIA, IFNA21, RNASEL, STAT1, SFRS1, SFRS2, SFRS5, BIRC3, PDIA3, PIK3CB, ZNF443, ZNF211, ZNF83, ZNF302, ZNF304, ZNF7, ZNF43, ZNF85, ZNF140, ZNF189, ZNF212, BCL2 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P33260 | CYP2C18 | Cytochrome P450 2C18 | Q9UKJ0 | PILRB | Paired immunoglobulin-like type 2 receptor beta | -0.762 | P33260 | CYP2C18 | Cytochrome P450 2C18 | Q06124 | PTPN11 | Tyrosine-protein phosphatase non-receptor type 11 | 0.742 | P27707 | DCK | Deoxycytidine kinase | O60603 | TLR2 | Toll-like receptor 2 | -0.781 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.73 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.825 | P27707 | DCK | Deoxycytidine kinase | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.89 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.868 | P27707 | DCK | Deoxycytidine kinase | P01568 | IFNA21 | Interferon alpha-21 | 0.798 | P33260 | CYP2C18 | Cytochrome P450 2C18 | P01568 | IFNA21 | Interferon alpha-21 | 0.86 | P27707 | DCK | Deoxycytidine kinase | Q05823 | RNASEL | 2-5A-dependent ribonuclease | -0.752 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.841 | P27707 | DCK | Deoxycytidine kinase | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | -0.7 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.935 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.703 | P27707 | DCK | Deoxycytidine kinase | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.804 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.882 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.781 | P33260 | CYP2C18 | Cytochrome P450 2C18 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.817 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.886 | P27707 | DCK | Deoxycytidine kinase | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.757 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.747 | P27707 | DCK | Deoxycytidine kinase | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.731 | P33260 | CYP2C18 | Cytochrome P450 2C18 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.752 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P30101 | PDIA3 | Protein disulfide-isomerase A3 | 0.739 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.743 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Q9Y2A4 | ZNF443 | Zinc finger protein 443 | 0.731 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q13398 | ZNF211 | Zinc finger protein 211 | 0.956 | P27707 | DCK | Deoxycytidine kinase | Q13398 | ZNF211 | Zinc finger protein 211 | -0.719 | P33260 | CYP2C18 | Cytochrome P450 2C18 | Q13398 | ZNF211 | Zinc finger protein 211 | -0.743 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | P51522 | ZNF83 | Zinc finger protein 83 | 0.851 | P27707 | DCK | Deoxycytidine kinase | P51522 | ZNF83 | Zinc finger protein 83 | 0.811 | P27707 | DCK | Deoxycytidine kinase | Q9NR11 | ZNF302 | Zinc finger protein 302 | 0.759 | P33260 | CYP2C18 | Cytochrome P450 2C18 | Q9NR11 | ZNF302 | Zinc finger protein 302 | 0.7 | P27707 | DCK | Deoxycytidine kinase | Q9HCX3 | ZNF304 | Zinc finger protein 304 | 0.737 | P27707 | DCK | Deoxycytidine kinase | P17097 | ZNF7 | Zinc finger protein 7 | 0.8 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | P17038 | ZNF43 | Zinc finger protein 43 | 0.718 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q03923 | ZNF85 | Zinc finger protein 85 | -0.731 | P27707 | DCK | Deoxycytidine kinase | Q03923 | ZNF85 | Zinc finger protein 85 | 0.731 | P33260 | CYP2C18 | Cytochrome P450 2C18 | Q03923 | ZNF85 | Zinc finger protein 85 | 0.723 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | P52738 | ZNF140 | Zinc finger protein 140 | 0.71 | P27707 | DCK | Deoxycytidine kinase | P52738 | ZNF140 | Zinc finger protein 140 | 0.789 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | O75820 | ZNF189 | Zinc finger protein 189 | -0.756 | Q13627 | DYRK1A | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | O75820 | ZNF189 | Zinc finger protein 189 | 0.768 | P27707 | DCK | Deoxycytidine kinase | O75820 | ZNF189 | Zinc finger protein 189 | 0.801 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q9UDV6 | ZNF212 | Zinc finger protein 212 | 0.798 | P33260 | CYP2C18 | Cytochrome P450 2C18 | Q9UDV6 | ZNF212 | Zinc finger protein 212 | -0.752 | P27707 | DCK | Deoxycytidine kinase | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.781 | P33260 | CYP2C18 | Cytochrome P450 2C18 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.784 |
| Sulfaphenazole | hsa05169 | Epstein-Barr virus infection | 3.48E-03 | 14 | P13765, Q13547, O00463, Q16539, P42338, P07948, Q13761, P24522, O75293, P01375, P29728, P07766, P09693, P20963 | HLA-DOB, HDAC1, TRAF5, MAPK14, PIK3CB, LYN, RUNX3, GADD45A, GADD45B, TNF, OAS2, CD3E, CD3G, CD247 | More | | Sulfaphenazole | hsa05170 | Human immunodeficiency virus 1 infection | 5.56E-04 | 11 | P31751, P42338, P62873, P50151, P0DP23, P17252, P30101, P01568, P25963, P19174, P23528 | AKT2, PIK3CB, GNB1, GNG10, CALM1, PRKCA, PDIA3, IFNA21, NFKBIA, PLCG1, CFL1 | More | | Sulfaphenazole | hsa05171 | Coronavirus disease - COVID-19 | 4.35E-03 | 14 | P01584, P25963, P42224, P01568, P62753, P36578, P62888, P61927, P61513, P62829, P40189, P42338, P19174, P17252 | IL1B, NFKBIA, STAT1, IFNA21, RPS6, RPL4, RPL30, RPL37, RPL37A, RPL23, IL6ST, PIK3CB, PLCG1, PRKCA | More | | Sulfaphenazole | hsa05200 | Pathways in cancer | 8.39E-06 | 22 | Q13751, P42338, P08238, P42224, P25963, P19174, P17252, P43246, P10826, P14923, Q13489, P49767, P14921, P31751, P62873, P50151, P78417, O75293, P0DP23, P01568, P14784, P40189 | LAMB3, PIK3CB, HSP90AB1, STAT1, NFKBIA, PLCG1, PRKCA, MSH2, RARB, JUP, BIRC3, VEGFC, ETS1, AKT2, GNB1, GNG10, GSTO1, GADD45B, CALM1, IFNA21, IL2RB, IL6ST | More | | Sulfaphenazole | hsa05202 | Transcriptional misregulation in cancer | 1.40E-03 | 15 | Q12778, Q15532, Q13315, P41732, P14780, P27930, P14923, Q16548, Q13077, O15550, P35226, P05164, P08246, Q9C0K0, P24522 | FOXO1, SS18, ATM, TSPAN7, MMP9, IL1R2, JUP, BCL2A1, TRAF1, UTX, BMI1, MPO, ELA2, BCL11B, GADD45A | More | | Sulfaphenazole | hsa05203 | Viral carcinogenesis | 4.85E-02 | 3 | Q15283, P62807, O60814 | RASA2, HIST1H2BC, H2BC12 | More | | Sulfaphenazole | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Sulfaphenazole | hsa05211 | Renal cell carcinoma | 2.01E-03 | 3 | Q06124, Q99814, P31751 | PTPN11, EPAS1, AKT2 | More | | Sulfaphenazole | hsa05212 | Pancreatic cancer | 4.51E-03 | 3 | P31751, P04637, P24522 | AKT2, TP53, GADD45A | More | | Sulfaphenazole | hsa05213 | Endometrial cancer | 2.80E-04 | 4 | Q13418, P31751, P04637, P24522 | ILK, AKT2, TP53, GADD45A | More | | Sulfaphenazole | hsa05214 | Glioma | 6.12E-06 | 8 | P0DP23, P17252, P42338, P31751, P04637, P19174, P24522, O75293 | CALM1, PRKCA, PIK3CB, AKT2, TP53, PLCG1, GADD45A, GADD45B | More | | Sulfaphenazole | hsa05216 | Thyroid cancer | 1.45E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Sulfaphenazole | hsa05217 | Basal cell carcinoma | 2.60E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Sulfaphenazole | hsa05218 | Melanoma | 1.19E-03 | 3 | P04637, P31751, P24522 | TP53, AKT2, GADD45A | More | | Sulfaphenazole | hsa05219 | Bladder cancer | 4.07E-02 | 2 | P14780, P04637 | MMP9, TP53 | More | | Sulfaphenazole | hsa05220 | Chronic myeloid leukemia | 8.51E-04 | 4 | Q06124, P04637, P31751, P24522 | PTPN11, TP53, AKT2, GADD45A | More | | Sulfaphenazole | hsa05221 | Acute myeloid leukemia | 4.19E-02 | 1 | P31751 | AKT2 | More | | Sulfaphenazole | hsa05222 | Small cell lung cancer | 1.14E-03 | 7 | P10826, P31751, P42338, Q13751, Q13489, P25963, O75293 | RARB, AKT2, PIK3CB, LAMB3, BIRC3, NFKBIA, GADD45B | More | | Sulfaphenazole | hsa05223 | Non-small cell lung cancer | 3.97E-05 | 8 | P17252, P31751, P42338, P19174, P10826, P04637, P24522, O75293 | PRKCA, AKT2, PIK3CB, PLCG1, RARB, TP53, GADD45A, GADD45B | More | | Sulfaphenazole | hsa05224 | Breast cancer | 4.75E-02 | 4 | P49841, Q92837, P04637, P24522 | GSK3B, FRAT1, TP53, GADD45A | More | | Sulfaphenazole | hsa05225 | Hepatocellular carcinoma | 4.54E-02 | 3 | P04637, P24522, P63261 | TP53, GADD45A, ACTG1 | More | | Sulfaphenazole | hsa05226 | Gastric cancer | 3.60E-02 | 1 | P31751 | AKT2 | More | | Sulfaphenazole | hsa05230 | Central carbon metabolism in cancer | 4.78E-02 | 1 | P31751 | AKT2 | More | | Sulfaphenazole | hsa05231 | Choline metabolism in cancer | 4.91E-03 | 5 | P42338, Q9Y259, P19174, P23743, P17252 | PIK3CB, CHKB, PLCG1, DGKA, PRKCA | More | | Sulfaphenazole | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 3.66E-04 | 10 | O95267, P07766, P20963, P09693, P06239, O60603, P10747, Q04759, Q16539, P01730 | RASGRP1, CD3E, CD247, CD3G, LCK, TLR2, CD28, PRKCQ, MAPK14, CD4 | More | | Sulfaphenazole | hsa05310 | Asthma | 2.48E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Sulfaphenazole | hsa05321 | Inflammatory bowel disease | 7.47E-05 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Sulfaphenazole | hsa05322 | Systemic lupus erythematosus | 1.31E-04 | 5 | P09871, Q93077, P62807, O60814, P68431 | C1S, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Sulfaphenazole | hsa05323 | Rheumatoid arthritis | 1.60E-02 | 4 | P13765, P10747, P09341, O60603 | HLA-DOB, CD28, CXCL1, TLR2 | More | | Sulfaphenazole | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Sulfaphenazole | hsa05332 | Graft-versus-host disease | 4.14E-05 | 6 | P13765, P48023, P10747, P01375, P26715, Q13241 | HLA-DOB, FASLG, CD28, TNF, KLRC1, KLRD1 | More | | Sulfaphenazole | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | Sulfaphenazole | hsa05418 | Fluid shear stress and atherosclerosis | 1.27E-05 | 10 | Q16539, P31751, Q14145, P10599, P14780, P01375, P04637, P14778, P27930, P0DP23 | MAPK14, AKT2, KEAP1, TXN, MMP9, TNF, TP53, IL1R1, IL1R2, CALM1 | More | | |